News

With the approval of this additional administration option, physicians will soon have the flexibility to prescribe GRANIX for either in-office or at home use. GRANIX, a leukocyte growth

Undertaken at the US Army Medical Research Institute of Infectious Diseases (USAMRIID), the proof-of-concept study was focused on assessing the effect of BCX4430 treatment on survival through day

Rosacea is a common, but often misunderstood, skin disorder affecting 16 million Americans,predominantly women, ages 30 and older. Although the cause of rosacea is unknown, research suggests that

By using real-world evidence, the two parties will focus on developing answers to commonly asked clinical questions about the continuum of diabetes care, such as the role and

The approval was based by data from over 2,700 subjects treated with peramivir in 27 clinical trials. University of Alabama Dr Richard Whitley said: "RAPIVAB is the first

Opdivo is a human programed death receptor-1 (PD-1) blocking antibody indicated to treat this skin cancer. The indication is approved under accelerated approval based on tumor response rate

This patent includes AC-201 or its pharmaceutically acceptable salts, active metabolite for treatment of type II diabetes. The patent also covers the methods of treatment using AC-201 for

"This is the second jurisdiction in which we have elected to file for Orphan Designation," said Dr. Brad Thompson , President and CEO of Oncolytics. "The EMA serves

L-Bcl-2 is a liposomal encapsulated oligonucleotide targeted to the translation initiation site of human Bcl-2 mRNA. The antisense oligonucleotide in L-Bcl-2 is a nuclease-resistant, hydrophobic analog of phosphodiesters